- Home
- IFRX vs HYPR Comparison
IFRX vs HYPR Comparison
Compare IFRX & HYPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- HYPR
- Stock Information
- Founded
- IFRX 2007
- HYPR 2014
- Country
- IFRX Germany
- HYPR United States
- Employees
- IFRX N/A
- HYPR N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- HYPR Medical Specialities
- Sector
- IFRX Health Care
- HYPR Health Care
- Exchange
- IFRX Nasdaq
- HYPR Nasdaq
- Market Cap
- IFRX 53.5M
- HYPR 55.9M
- IPO Year
- IFRX 2017
- HYPR N/A
- Fundamental
- Price
- IFRX $0.85
- HYPR $0.78
- Analyst Decision
- IFRX Strong Buy
- HYPR Strong Buy
- Analyst Count
- IFRX 4
- HYPR 3
- Target Price
- IFRX $7.75
- HYPR $1.06
- AVG Volume (30 Days)
- IFRX 371.5K
- HYPR 240.2K
- Earning Date
- IFRX 08-07-2025
- HYPR 08-07-2025
- Dividend Yield
- IFRX N/A
- HYPR N/A
- EPS Growth
- IFRX N/A
- HYPR N/A
- EPS
- IFRX N/A
- HYPR N/A
- Revenue
- IFRX $140,242.00
- HYPR $11,732,000.00
- Revenue This Year
- IFRX N/A
- HYPR $12.31
- Revenue Next Year
- IFRX $6,309.47
- HYPR $29.29
- P/E Ratio
- IFRX N/A
- HYPR N/A
- Revenue Growth
- IFRX 30.90
- HYPR 0.34
- 52 Week Low
- IFRX $0.71
- HYPR $0.53
- 52 Week High
- IFRX $2.82
- HYPR $1.90
- Technical
- Relative Strength Index (RSI)
- IFRX 45.30
- HYPR 54.54
- Support Level
- IFRX $0.78
- HYPR $0.76
- Resistance Level
- IFRX $0.93
- HYPR $0.83
- Average True Range (ATR)
- IFRX 0.05
- HYPR 0.04
- MACD
- IFRX 0.03
- HYPR 0.00
- Stochastic Oscillator
- IFRX 42.32
- HYPR 66.67
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About HYPR Hyperfine Inc.
Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales which consist of sales from subscriptions of bundled devices, maintenance, and software.